Author

J. T. Wilson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

M. Wehbe· 2 shared A. J. Kwiatkowski· 1 shared A. K. von Lersner· 1 shared A. M. Pyle· 1 shared A. M. Weaver· 1 shared A. Richmond· 1 shared A. Weaver· 1 shared A. Zijlstra· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

M. Wehbe

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy

T. L. Sheehy, A. J. Kwiatkowski, K. Arora, B. R. Kimmel, J. A. Schulman, K. Gibson-Corley, J. T. Wilson

This paper develops SAPCon, a polymer-drug conjugate that activates the STING pathway in tumors, enhancing immunotherapy efficacy by promoting an immunogenic microenvironment and improving tumor growth inhibition.

bioRxiv · Mar 23, 2024Bioengineering

Culture conditions greatly impact the levels of vesicular and extravesicular Ago2 and RNA in extracellular vesicle preparations.

L. Jimenez, B. Barman, Y. J. Jung, L. N. Cocozza, E. Krystofiak, C. E. Saffold, K. C. Vickers, J. T. Wilson, T. R. Dawson, A. M. Weaver

The paper investigates how culture conditions affect the levels of Ago2 and RNA in extracellular vesicles, finding that serum and cell state influence their presence.

bioRxiv · Jun 21, 2023Cancer Biology

A Nanoparticle RIG-I Agonist for Cancer Immunotherapy

L. Wang-Bishop, M. Wehbe, L. E. Pastora, J. Yang, K. M. Garland, K. W. Becker, C. S. Carson, K. N. Gibson-Corley, D. Ulkoski, V. Krishnamurthy, O. Fedorova, A. Richmond, A. M. Pyle, J. T. Wilson

This paper develops SLR-LNPs, a nanoparticle-based RIG-I agonist, showing enhanced tumor immunogenicity and improved response to immune checkpoint inhibitors in mouse cancer models.

bioRxiv · Apr 25, 2023 · PreprintBioengineering

EV Fingerprinting: Resolving extracellular vesicle heterogeneity using multi-parametric flow cytometry

A. K. von Lersner, F. C. L. Fernandes, P. M. M. Ozawa, T. Vagner, S. M. Lima, B. H. Sung, M. Wehbe, K. Franze, J. T. Wilson, J. M. Irish, A. Weaver, D. Di Vizio, A. Zijlstra

EV Fingerprinting uses flow cytometry to resolve EV heterogeneity and detect tumor-derived EVs in plasma.

bioRxiv · Nov 10, 2022 · PreprintCell Biology